NH Nonghyup Life Insurance is launching a product that guarantees up to 100 million KRW annually for cancer treatment costs for 10 years.
On the 7th, NH Nonghyup Life Insurance announced that starting from the 8th, it will newly release the 'Cancer Plus NH Treatment Insurance (renewable, non-renewable, non-dividend)'. When subscribing to the main contract with a coverage amount of 10 million KRW, the insured will receive annual cancer major medical expenses from a minimum of 3 million KRW to a maximum of 100 million KRW for 10 years based on Type 1 (basic plan).
The coverage is proportional to the cancer treatment costs borne by the customer, and unlike existing cancer insurance that pays a one-time diagnosis benefit and then expires, it is designed to refill the coverage amount up to 100 million KRW annually. The payment period after cancer occurrence is 10 years, and the scope of cancer treatment coverage has been expanded from surgery, radiation, and medication to the entire cancer-related benefit portion.
Additional coverage for income loss can be added through the Cancer Income Compensation Support Rider and Continuous Cancer Income Support Rider. These riders are designed to alleviate concerns about income interruption during cancer treatment, and for Type 2 (non-renewable), a fixed payment of 1 million KRW per month for 12 months is made up to age 100.
Existing customers who exceed the cancer diagnosis benefit subscription limit with Nonghyup Life Insurance can also subscribe to this cancer treatment insurance. For customers maintaining normal subscription to Nonghyup Life Insurance products, a 2% discount on the main contract premium is applied, and those who have subscribed to Nonghyup Life Insurance cancer insurance (after 90 days of subscription) can subscribe under the Cancer Direct Guarantee type.
Only for the simplified subscription type, customers with pre-existing conditions or advanced age can subscribe. If the customer does not fall under any of the three disclosure items?▲ doctor's necessary opinion on hospitalization, surgery, or additional examination within 3 months, confirmed or suspected diagnosis of disease ▲ hospitalization and surgery (including cesarean section) within 2 years ▲ diagnosis, hospitalization, or surgery for cancer within 5 years?they can subscribe.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.


